Former W&M Aide: Another Plus To 340B Reform May Be Lower ACA Premiums

By Gabrielle Wanneh / October 27, 2025 at 5:51 PM

A former House Ways & Means staffer told Inside Health Policy that as Senate lawmakers craft a 340B reform bill, they should consider that the current drug discount program is contributing to higher Affordable Care Act (ACA) premiums and the way they craft the reforms could allow a possible extension of the expiring ACA enhanced subsidies to be more cost-effective.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.